 Loss of TLR9 exacerbates progression of SLE, and leads to increased activation of dendritic cells.TLR9 also controls the release of IgA and IFN-a in SLE, and loss of the receptor leads to higher levels of both molecules.In SLE, TLR9 and TLR7 have opposing effects.